Current Research and Development of Chemotherapeutic Agents for Melanoma
Cutaneous malignant melanoma is the most lethal form of skin cancer and an increasingly common disease worldwide. It remains one of the most treatment-refractory malignancies. The current treatment options for patients with metastatic melanoma are limited and in most cases non-curative. This review...
Main Authors: | Kyaw Minn Hsan, Chun-Chieh Chen, Lie-Fen Shyur |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/2/2/397/ |
Similar Items
-
Schwannomas mistaken for metastases of melanoma in PET‐CT: A diagnostic challenge with consequences
by: Stefanie Hirsiger, et al.
Published: (2022-12-01) -
Cutaneous horn malignant melanoma
by: Haruto Nishida, et al.
Published: (2013-12-01) -
Cutaneous melanoma in childhood presenting as intraparotid lymph node metastasis
by: Abhishek Kumar, et al.
Published: (2018-01-01) -
Primary retroperitoneal melanoma presented in a rare extracutaneous site for malignant melanoma
by: Mohamed Alsharedi, et al.
Published: (2016-10-01) -
Evaluation of cutaneous side-effects associated with
chemotherapeutic use in oncological patients
by: Zeynep Utlu, et al.
Published: (2021-10-01)